Tormentic Acid, a New Hypoglycemic Agent from Poterium ancistroides.

Tormentic Acid, a New Hypoglycemic Agent from Poterium ancistroides. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Tormentic Acid, a New Hypoglycemic Agent from Poterium ancistroides. Abstract Text:

A Villar,M ,M D ,D Cortes,

The hypoglycemic activity of POTERIUM ANCISTROIDES Desf. (Rosaceae) was studied. An active principle with a triterpene structure, tormentic acid, was isolated and elucidated by spectroscopic methods. Likewise, its hypoglycemie activity was established and compared with that of glibenclamide.

Tormentic Acid, a New Hypoglycemic Agent from Poterium ancistroides. Publishing Authors By Initials

A Villar,M ,MD ,D Cortes,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Tormentic Acid, a New Hypoglycemic Agent from Poterium ancistroides. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Planta medica

VOLUME: 52

Page Numbers: 43-5

Journal Abbreviation: Planta Med.

ISSN: 0032-0943

DAY: 8

MONTH: Feb

YEAR: 1986

Tormentic Acid, a New Hypoglycemic Agent from Poterium ancistroides. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 66751

Tormentic Acid, a New Hypoglycemic Agent from Poterium ancistroides. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Tormentic Acid, a New Hypoglycemic Agent from Poterium ancistroides. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Tormentic Acid, a New Hypoglycemic Agent from Poterium ancistroides.

AFFILIATION: Departamento de Farmacognosia y Farmacodinamia. Facultad de Farmacia. Universidad de Valencia, Avda. Blasco Ibañez, 13 46010 Valencia, España.

Country: Germany

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Planta Med

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Tormentic Acid, a New Hypoglycemic Agent from Poterium ancistroides Related Publications

• Acute lung injury associated with docetaxel and bevacizumab.
• Capillary flow technology with multi-dimensional gas chromatography for trace analysis of oxygenated compounds in complex hydrocarbon matrices.
• Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase.
• Chronic ethanol consumption in rats produces residual increases in anxiety 4 months after withdrawal.
• Cytogenetic and molecular responses and outcome in chronic myelogenous leukemia: need for new response definitions?
• E08 New tyrosine kinase inhibitors in chronic myeloid leukemia (CML).
• Extramedullary BCR-ABL1-negative myeloid leukemia in a patient with chronic myeloid leukemia and synchronous cytogenetic abnormalities in Philadelphia-positive and -negative clones during imatinib therapy.
• Gait pattern normalization after lateral retinaculum reconstruction for iatrogenic medial patellar instability.
• Hepatocellular carcinoma.
• Homoharringtonine for the treatment of chronic myelogenous leukemia.
• Hypolaetin-8-O-Glucoside, An Anti-inflammatory Flavonoid from Sideritis mugronensis.
• Inferior Vena Cava Anomalies during Laparoscopic Retroperitoneal Lymph Node Dissection.
• Instability of hexane-acetonitrile mobile phases used for the chromatographic analysis of triacylglycerides.
• Knee Pain An Unusual Running Injury: 1090: June 1 9:00 AM 9:20 AM.
• Management of diaphragmatic injury during transperitoneal laparoscopic urological procedures.
• Monitoring the response and course of chronic myeloid leukemia in the modern era of BCR-ABL tyrosine kinase inhibitors: practical advice on the use and interpretation of monitoring methods.
• Nilotinib therapy in chronic myelogenous leukemia.
• Pediculosis in Macaca sylvanus of Gibraltar.
• Protection of halogenated DNA from strand breakage and sister-chromatid exchange induced by the topoisomerase I inhibitor camptothecin.
• Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review.
• Sequencing of subcloned PCR products facilitates earlier detection of BCR-ABL1(T315I) and other mutants compared to direct sequencing of the ABL1 kinase domain.
• Situated robotics: from learning to teaching by imitation.
• Tormentic Acid, a New Hypoglycemic Agent from Poterium ancistroides.
• [Aerial image in mediastinum]
• [Detection of primary antiretroviral resistance in Chilean patients recently infected with human immunodeficiency virus (HIV).]
• [Not Available.]
• [Not Available.]
• [Pseudotumoral adenomyomatosis of the gallbladder diagnosed by ultrasound: Report of one case.]
• [Strabismus and congenital cataracts]
• [Therapeutic approach to Staphylococcus aureus bacteremia]